ZR9-13015-83933
2 vaccinations
2 coded responses
18 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 968 / HI
- Registered
- 2021-02-21
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-20
Dose 1 — Pfizer-BioNTech
-
2021-02-21
Registered in v-safe
-
2021-02-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-02-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-02-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-25
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-26
Survey response — days 1–6 daily, dose 1MedDRA: Axillary pain — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Injected arm pit sorenessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-02-27
Health check-in — day 7, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-27
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-03-06
-
2021-03-13
Dose 2 — Pfizer-BioNTech
- 2021-03-13
-
2021-03-14
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Labored breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-20
- 2021-03-27
- 2021-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-20 | Pfizer-BioNTech | |
| 2 | 2021-03-13 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-25 | priority 2/3 | |
| 2021-02-26 | priority 2/3 | |
| 2021-02-27 | priority 2/3 |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Injected arm pit soreness
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Labored breathing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release